Novartis Investigative Site
La Mesa, California 91942
0 studies enrolling now · 8 studies all time
What they study most
Ankylosing Spondylitis, COVID-19 Pneumonia, Impaired Respiratory Function, Osteoporosis, Psoriatic Arthritis, Tendinopathy
Studies at this site
- Study to Demonstrate the Efficacy, Safety and Tolerability of Intravenous Secukinumab up to 52 Weeks in Subjects With Active Psoriatic Arthritis — Completed
- Study to Demonstrate the Efficacy, Safety and Tolerability of an Intravenous Regimen of Secukinumab Compared to Placebo in Subjects With Active axSpA — Completed
- Effect of Secukinumab on Radiographic Progression in Ankylosing Spondylitis as Compared to GP2017 (Adalimumab Biosimilar) — Completed
- Study of Efficacy and Safety of MAS825 in Patients With COVID-19 — Completed
- Study of Efficacy, Safety and Tolerability of AIN457 in Patients With Active Overuse Tendinopathy — Completed
- Study to Evaluate the Safety and Efficacy of Secukinumab 300 mg and 150 mg in Adult Patients With Active Psoriatic Arthritis (PsA) After 16 Weeks of Treatment Compared to Placebo — Completed
- Efficacy of Secukinumab Compared to Adalimumab in Patients With Psoriatic Arthritis — Completed
- Efficacy Study of Zoledronic Acid and Teriparatide Combination Therapy in Women With Osteoporosis — Completed